These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 8626839

  • 1. Outcome of a four-year randomized study of daily versus three times weekly somatropin treatment in prepubertal naive growth hormone-deficient children. Genentech Study Group.
    MacGillivray MH, Baptista J, Johanson A.
    J Clin Endocrinol Metab; 1996 May; 81(5):1806-9. PubMed ID: 8626839
    [Abstract] [Full Text] [Related]

  • 2. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [Abstract] [Full Text] [Related]

  • 3. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frölich M, Oostdijk W, Wit JM.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [Abstract] [Full Text] [Related]

  • 4. Linear growth response to recombinant human growth hormone in children with growth hormone deficiency.
    Shih KC, Ho LT, Kuo HF, Chang TC, Liu PC, Chen CK, Tiu CM.
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jul; 54(1):7-13. PubMed ID: 8087727
    [Abstract] [Full Text] [Related]

  • 5. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
    Rappaport R, Mugnier E, Limoni C, Crosnier H, Czernichow P, Leger J, Limal JM, Rochiccioli P, Soskin S.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
    [Abstract] [Full Text] [Related]

  • 6. The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome.
    Cotterill AM, McKenna WJ, Brady AF, Sharland M, Elsawi M, Yamada M, Camacho-Hübner C, Kelnar CJ, Dunger DB, Patton MA, Savage MO.
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2291-7. PubMed ID: 8964866
    [Abstract] [Full Text] [Related]

  • 7. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [Abstract] [Full Text] [Related]

  • 8. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 9. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
    Quintos JB, Vogiatzi MG, Harbison MD, New MI.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years.
    de Zegher F, Albertsson-Wikland K, Wollmann HA, Chatelain P, Chaussain JL, Löfström A, Jonsson B, Rosenfeld RG.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2816-21. PubMed ID: 10946888
    [Abstract] [Full Text] [Related]

  • 12. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [Abstract] [Full Text] [Related]

  • 13. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial.
    Mericq MV, Eggers M, Avila A, Cutler GB, Cassorla F.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):569-73. PubMed ID: 10690857
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.
    Blum WF, Crowe BJ, Quigley CA, Jung H, Cao D, Ross JL, Braun L, Rappold G, SHOX Study Group.
    J Clin Endocrinol Metab; 2007 Jan; 92(1):219-28. PubMed ID: 17047016
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M, Bjarnason R, Rosberg S, Carlsson LM, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [Abstract] [Full Text] [Related]

  • 16. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
    Guevara-Aguirre J, Rosenbloom AL, Vasconez O, Martinez V, Gargosky SE, Allen L, Rosenfeld RG.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
    [Abstract] [Full Text] [Related]

  • 17. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
    Vanderschueren-Lodeweyckx M, Massa G, Maes M, Craen M, van Vliet G, Heinrichs C, Malvaux P.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
    [Abstract] [Full Text] [Related]

  • 18. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
    Lampit M, Hochberg Z.
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
    [Abstract] [Full Text] [Related]

  • 19. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC, Stijnen T, De Jong MC, Donckerwolcke RA, De Muinck Keizer-Schrama SM, Blum WF, Drop SL.
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [Abstract] [Full Text] [Related]

  • 20. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
    Pasquino AM, Municchi G, Pucarelli I, Segni M, Mancini MA, Troiani S.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.